RDNT Stock Analysis: Buy, Sell, or Hold?

RDNT - RadNet, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$77.05
1.51 (2.00%) ▲
5d: -0.34%
30d: +30.11%
90d: +42.13%
WAIT
LOW Confidence
Protect Your RDNT Gains
Analysis Updated: Aug 20, 2026 12:00 AM ET
Earnings: Aug 10, 2026 0d

Get Alerted When RDNT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: RDNT shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$43.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.80
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: RDNT is currently trading at $77.05, which is considered extended relative to its 30-day fair value range of $61.24 to $74.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 86.9) compared to its historical average (72.5). At these levels, the market is pricing in 6.2% annual earnings growth.

Technical Outlook: Technically, RDNT is in a strong uptrend. The price is approaching resistance at $78.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: RDNT scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $92.88 (+20.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $61.24 - $74.05
Company Quality Score 37/100 (SELL)
Volume Confirmation HIGH
Confidence Score 45.0%

Protect Your Profits

Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 20.5% below Wall St target ($92.88)
  • BULLISH: Expecting earnings turnaround to 6.2% growth with 25.0% revenue growth
  • WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $61.24 - $74.05
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$6.19 (8.0%)

Support & Resistance Levels

Support Level $67.94
Resistance Level $78.86
Current Trend Strong Uptrend
Technical data as of Aug 20, 2026

Fundamental Context

Forward P/E (Next Year Est.) 86.90
Wall Street Target $92.88 (+20.5%)
Revenue Growth (YoY) 25.0%
Earnings Growth (YoY) -49.1%
Profit Margin -0.9%
Valuation Premium vs History +6.2% premium
PE vs Historical 86.9 vs 72.5 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.2% (market-implied from PE analysis)
1-Year Target $81.83 (+6%)
2-Year Target $86.90 (+13%)
3-Year Target $92.29 (+20%)
3-Yr Target (if PE normalizes) (PE: 87→73) PE COMPRESSION $77.00 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 86.9, Growth: 72.4%) $260.04 (+238%)
Base: (SPY PE: 20.1, Growth: 72.4%) $60.06 (-22%)
Bear: (PE: 17.1, Growth: 72.4%) $51.05 (-34%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 21, 2026 9:47 AM ET
Data refreshes hourly during market hours. Next update: 10:47 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Alma Gregory Sorensen SELL 15000 shares 2026-03-18

Unlock Insider Activity

See real-time buying/selling by company executives for RDNT.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$631 41 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 52 HOLD
GH
Guardant Health Inc
STRONG BUY
23 analysts
$194 43 HOLD
DHR
Danaher Corporation
STRONG BUY
25 analysts
$228 40 SELL
NTRA
Natera Inc
STRONG BUY
21 analysts
$331 38 SELL

Advanced RDNT Option Strategies

Professional options setups generated by AI based on today's RDNT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RDNT

RDNT Technical Chart RDNT Price Prediction RDNT Earnings Date RDNT Investment Advisor RDNT Fair Price Analyzer RDNT Options Advisor RDNT Options Chain RDNT Options Analysis RDNT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals